title: Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148.
authors.forename: P
authors.initials: P
authors.lastname: Limonta
authors.forename: G
authors.initials: G
authors.lastname: Pratesi
authors.forename: R M
authors.initials: RM
authors.lastname: Moretti
authors.forename: M
authors.initials: M
authors.lastname: Montagnani Marelli
authors.forename: M
authors.initials: M
authors.lastname: Motta
authors.forename: D
authors.initials: D
authors.lastname: Dondi
mesh_terms: D001839:Bombesin / Q000031:analogs & derivatives / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology; D006727:Hormone Antagonists / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000473:pathology*
chemical_list: D006727:Hormone Antagonists; D010446:Peptide Fragments; C096400:bombesin(6-14), Hca(6)-Leu(13)-psi(CH2N)-Tac(14)-; D007987:Gonadotropin-Releasing Hormone; C062876:cetrorelix; D001839:Bombesin